Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00313859 | Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC | completed | Phase 2 | 50 | Samsung Medical CenterOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT01372189 | Molecular Imaging of Epidermal Growth Factor Receptor in Colorectal Neoplasia Using Confocal Laser Endomicroscopy | completed | — | 40 | Shandong UniversityOTHER | 1 | Feb 1, 2012 | clinicaltrials |
| NCT00969033 | CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With Oxaliplatin | terminated | Phase 2 | 8 | Daiichi SankyoINDUSTRY | 1 | Jan 31, 2012 | clinicaltrials |
| NCT00581724 | Pain in Cancer Survivors | completed | — | 200 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 26, 2012 | clinicaltrials |
| NCT01518023 | Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy | completed | — | 240 | University of Sao PauloOTHER | 1 | Jan 25, 2012 | clinicaltrials |
| NCT00062348 | Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases | completed | Phase 1 | 27 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00122291 | A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer | unknown | Phase 2 | 66 | Alberta Health servicesOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT00690677 | Phase II Trial of LBH589 in Refractory Colorectal Cancer | completed | Phase 2 | 29 | Swedish Medical CenterOTHER | 1 | Jan 18, 2012 | clinicaltrials |
| NCT00891332 | Study of S-1 Plus LV for Untreated Metastatic Colorectal Cancer | completed | Phase 2 | 73 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 2 | Jan 18, 2012 | clinicaltrials |
| NCT00296062 | Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer | terminated | Phase 1 | 12 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 16, 2012 | clinicaltrials |
| NCT01505972 | Time Schedules for Sending Invitations to Colonoscopy Screening | completed | N/A | 1,600 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Jan 10, 2012 | clinicaltrials |
| NCT00297128 | Preoperative Chemoradiation With Capecitabine and Cetuximab | completed | Phase 2 | 31 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Dec 30, 2011 | clinicaltrials |
| NCT01042743 | Laparoscopic Surgery Versus Robot Surgery for Right-side Colon Cancer: Short-term Outcome of a Randomised Clinical Trial | completed | Phase 2 | 80 | Kyungpook National University HospitalOTHER | 1 | Dec 20, 2011 | clinicaltrials |
| NCT00422864 | A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer | completed | Phase 2 | 26 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Dec 15, 2011 | clinicaltrials |
| NCT01311050 | A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer | unknown | — | 46 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Dec 13, 2011 | clinicaltrials |
| NCT01489332 | Induction Chemotherapy,Radiochemotherapy, Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer | unknown | Phase 2 | 60 | Institute of Oncology LjubljanaOTHER | 1 | Dec 9, 2011 | clinicaltrials |
| NCT00860249 | Outreach for Patients That Are Newly Eligible for Colorectal Cancer Screening(UPQUAL) | terminated | N/A | 60 | Northwestern UniversityOTHER | 1 | Dec 5, 2011 | clinicaltrials |
| NCT01175291 | FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer | withdrawn | Phase 2 | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Dec 5, 2011 | clinicaltrials |
| NCT00911391 | Randomised Trial of Doppler-Optimised Fluid Balance in Elective Colectomy | completed | Phase 3 | 85 | University of Auckland, New ZealandOTHER | 1 | Nov 29, 2011 | clinicaltrials |
| NCT00982618 | Functional Restoration After Abdominal and Pelvic Laparoscopic Surgery: Effect of Perioperative Intravenous Lidocaine | completed | N/A | 60 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Nov 28, 2011 | clinicaltrials |
| NCT01155440 | Bowel Function After Laparoscopic Colon Surgery: Effect of IV Lidocaine | completed | Phase 2 | 60 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Nov 28, 2011 | clinicaltrials |
| NCT01477190 | Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program | completed | Phase 1 / Phase 2 | 40 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Nov 28, 2011 | clinicaltrials |
| NCT01182922 | Information About a Doctor or a Possibility of Choosing Doctor's Gender and Attendance to Screening Colonoscopy | completed | Early Phase 1 | 5,100 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Nov 18, 2011 | clinicaltrials |
| NCT01474187 | Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer | unknown | Phase 1 | 60 | Fudan UniversityOTHER | 1 | Nov 18, 2011 | clinicaltrials |
| NCT00866944 | Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases(MT201-204) | completed | Phase 2 | 35 | Amgen Research (Munich) GmbHINDUSTRY | 2 | Nov 11, 2011 | clinicaltrials |
| NCT01470586 | Surgical Resection Lowers Oxidative Stress Markers in Patients With Colorectal Cancer | completed | N/A | 60 | G. Hatzikosta General HospitalOTHER | 1 | Nov 11, 2011 | clinicaltrials |
| NCT01464918 | Safety and Efficacy of Using MASTER to Perform Endoscopic Submucosal Dissection in Human | unknown | N/A | 7 | National University Hospital, SingaporeOTHER | 3 | Nov 4, 2011 | clinicaltrials |
| NCT00779311 | A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer | terminated | Phase 1 | 8 | Accelerated Community Oncology Research NetworkOTHER | 1 | Nov 2, 2011 | clinicaltrials |
| NCT01214681 | Chemoprevention of Colorectal Cancer: the Role of Non-digestible Carbohydrates | unknown | N/A | 75 | Newcastle UniversityOTHER | 1 | Oct 26, 2011 | clinicaltrials |
| NCT01459328 | Resource-Sparing Curative Treatment for Rectal Cancer | unknown | Phase 3 | 350 | International Atomic Energy AgencyOTHER_GOV | 11 | Oct 25, 2011 | clinicaltrials |
| NCT00354978 | Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients | completed | Phase 2 | 49 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 21, 2011 | clinicaltrials |
| NCT01070355 | Eicosapentaenoic Acid (EPA) for Treatment of Colorectal Cancer Liver Metastases(EMT) | completed | Phase 2 | 88 | University of LeedsOTHER | 1 | Oct 21, 2011 | clinicaltrials |
| NCT01456923 | Chemotherapy With DNA Damaging Agents In Colorectal Cancer | completed | Phase 1 | — | Centro Hospitalar NordesteOTHER | 0 | Oct 21, 2011 | clinicaltrials |
| NCT01457287 | A Longitudinal Investigation of Cognitive Function in Colorectal Cancer Patients | completed | — | 300 | University Health Network, TorontoOTHER | 0 | Oct 21, 2011 | clinicaltrials |
| NCT01016639 | Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer(CORGI) | completed | Phase 1 / Phase 2 | 106 | Lund University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00451880 | Study of XL281 in Adults With Solid Tumors | completed | Phase 1 | 180 | ExelixisINDUSTRY | 1 | Oct 13, 2011 | clinicaltrials |
| NCT01048463 | Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor | unknown | Phase 3 | 90 | Sun Yat-sen UniversityOTHER | 1 | Oct 6, 2011 | clinicaltrials |
| NCT01440855 | Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community Setting | completed | N/A | 340 | Fox Chase Cancer CenterOTHER | 1 | Oct 4, 2011 | clinicaltrials |
| NCT00335491 | Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors | completed | N/A | 49 | University of UtahOTHER | 1 | Sep 30, 2011 | clinicaltrials |
| NCT01253837 | L19TNFα in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 34 | Philogen S.p.A.INDUSTRY | 1 | Sep 23, 2011 | clinicaltrials |
| NCT00380055 | Reducing Cancer Disparities for American Indians in the Rural Intermountain West | completed | N/A | 1,800 | University of UtahOTHER | 1 | Sep 21, 2011 | clinicaltrials |
| NCT01437618 | First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer | completed | — | 15 | Azienda Ospedaliero, Universitaria PisanaOTHER | 1 | Sep 21, 2011 | clinicaltrials |
| NCT00931840 | A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma | unknown | Phase 2 | 220 | Enzon Pharmaceuticals, Inc.INDUSTRY | 5 | Sep 20, 2011 | clinicaltrials |
| NCT01292681 | Multi-modality Imaging in the Prediction of Response to Systemic Treatment in Colorectal Cancer | unknown | N/A | 60 | Radboud University Medical CenterOTHER | 1 | Sep 8, 2011 | clinicaltrials |
| NCT00438737 | Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer | unknown | Phase 2 | 100 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Sep 2, 2011 | clinicaltrials |
| NCT00345696 | 1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR. | completed | Phase 2 | 32 | Unidad Integral de Investigación en Oncología S.L.OTHER | 1 | Aug 24, 2011 | clinicaltrials |
| NCT01292369 | Breath Testing for Breast and Colon Cancer Diagnosis- NaNose Study | unknown | — | 560 | Rambam Health Care CampusOTHER | 1 | Aug 18, 2011 | clinicaltrials |
| NCT01418391 | the Effect of the Transversus Abdominis Plane (TAP) Block on the Minimal Laparotomy : a Randomized Controlled Trial | unknown | N/A | 60 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Aug 17, 2011 | clinicaltrials |
| NCT01322178 | Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer Patients(CLIME) | unknown | Phase 2 | 90 | Fudan UniversityOTHER | 1 | Aug 12, 2011 | clinicaltrials |
| NCT00560365 | Follow-Up Study of Patients Who Have Undergone Surgery for Stage I, Stage II, or Stage III Colorectal Cancer | unknown | — | 4,760 | University Hospital Southampton NHS Foundation TrustOTHER | 1 | Aug 8, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Feb 2, 2012source: clinicaltrials